Moderna's COVID vaccine cleared for 12- to 17-year-olds in EU

The approval comes after a study involving more than 3,700 children.

Sean Keane Former Senior Writer
Sean knows far too much about Marvel, DC and Star Wars, and poured this knowledge into recaps and explainers on CNET. He also worked on breaking news, with a passion for tech, video game and culture.
Expertise Culture, Video Games, Breaking News
Sean Keane
Sarah Tew/CNET

The European Medicines Agency recommended authorizing Moderna's COVID-19 vaccine for 12- to 17-year-olds on Friday. It's still awaiting approval from the US Food and Drug Administration.

A study involving more than 3,700 children showed that the shots produced a comparable antibody response to that seen in adults, the EU regulator said. The nod comes nearly two months after Moderna announced the vaccine's efficacy in teenagers.

Previously, Pfizer's vaccine was the only one approved for teens in Europe, the Associated Press noted.

More than 137 million doses of Moderna's vaccine have been administered in the US as of Friday, according to data from the Centers for Disease Control and Prevention, and nearly 62 million people have been fully vaccinated with it. Across the 27 EU member states, more than 35 million doses have been administered, according to European Centre for Disease Prevention and Control data. 

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.